Published: Aug-2022|  Format: PDF | QY Research |  Number of pages: 89 | Code: MBI-3393436

Haemophilus Influenzae Type B Vaccine Market by Products (Liquid Monovalent HIB, Liquid Combination HIB, Lyophilized Monovalent HIB, Lyophilized Combination HIB), by Applications (Hospital, Research Institutions, Pharmaceutical and Biotechnology Companies, Academic Institutions) And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 - 2028

Select a Format




 Buy Now

The Global Haemophilus Influenzae Type B Vaccine Market was valued at USD XXX in 2022 and it is projected to surpass around USD XX by 2030 with a registered CAGR of xxx during the forecast period 2022 to 2030.

Growth factor

Our new latest report titled, global Haemophilus Influenzae Type B Vaccine Market comes up with comprehensive analysis of the industry including emerging trends and current development of the market. The report offers comprehensive insights of the industry with details of market share, size, revenue, growth opportunities, regional insights and major companies. The report provides all necessary and vital information related to the global market to help the buyer, the readers, investors get a complete understanding of the market and invest accordingly to the upcoming challenges and opportunities.

List of Key Players Operating in the Market:

The report provides in-depth research about each player operating in the global Haemophilus Influenzae Type B Vaccine Market along with its worldwide financial position, previous and upcoming business expansion plans, new product launches. The upcoming activities of the key players related to various strategies such as acquisitions, partnerships, mergers and, joint ventures, research and development investments.

  • Novartis
  • Merck
  • Sanofi
  • GlaxoSmithKline
  • Takeda Pharmaceuticals Company
  • Walvax Biotechnology
  • Lanzhou Institute of Biologica
  • Immunize BC

Market research report presents an analysis of all the data collected through primary and secondary resources. Our well experienced team of analyst collects all the information from several leading entities press release, government publication sources such as gold standard, silver standard, white papers, articles and websites, corporate filings including financial statements, annual reports, investor presentations, etc.

Our Report offers detailed insights market valuation, volume, share, outlook, production capacity and price analysis for the forecast period 2022-2030. Furthermore, the study also includes market segmentation on the basis of product, application, end-users, supply chain, distribution channel and other segment. Additionally, the study also includes market segmentation based on upstream downstream demand analysis, feedstock, and consumption rate and market share. It employs both primary and secondary methods of data collection to obtain relevant and sustainable information of the market.

This exclusive report includes detailed information about the market related activities such as Partnerships, stake holder position, Sole Traders, which create, develop, and conduct activities for the study and analysis of markets as per the customization and specifications of the client.

Segment Analysis of the Market:

The objective of the report mainly provides an essential overview of the Haemophilus Influenzae Type B Vaccine Market with detailed market segmentation by product, end-users, distribution channel, technology, content, type, application and region. The global market is expected to witness rapid growth during the forecast period. The report provides growth drivers, challenges, restraints of the region. It also offers the fastest growing segment with future scope, advancement emerging trends. The study examines the global scenario of the market by conducting an economy-wide assessment along with a comprehensive study involving product costs, drivers and restrictions, demands, profit analysis, production, distribution, and year-on-year growth rates.

By Type

  • Liquid Monovalent HIB
  • Liquid Combination HIB
  • Lyophilized Monovalent HIB
  • Lyophilized Combination HIB

By Application

  • Hospital
  • Research Institutions
  • Pharmaceutical and Biotechnology Companies
  • Academic Institutions
  • Other

Key Question Answered in this In-depth Market Report 2022-2028:

  • What was the market valued in the past year?
  • What will be the projected size, share and CAGR of the market?
  • What was the market status across the globe?
  • What are the profit margins in global Haemophilus Influenzae Type B Vaccine Market?
  • What are the growth factors boosts the market for the forecast period?
  • Which segment is going to boom in the near future?
  • What are the upcoming trends of the market?
  • Who are the key companies or players of the market?
  • Which is the fastest growing region of the global Haemophilus Influenzae Type B Vaccine Market?

Regional Insights:

The government initiative increasing the development activities of the Haemophilus Influenzae Type B Vaccine Market. On the other hand the major reason behind the growth is the market key players are expanding their operation in this region.

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Exclusive Report Offers:

  1. To study and analyze the global Haemophilus Influenzae Type B Vaccine Market consumption rate by key regions, type and application, historical data from past five years, and for upcoming years.
  2. The global research study look at the market to identify key influencing factors and entry barriers.
  3. To understand the structure of market by identifying and studying its various segments.
  4. To analyze with respect to individual prospects, growth factors, emerging trends, and their contribution to the whole market.
  5. Study focuses on the analysis of key players, to describe and analyze the sales volume, company size, share, value, market competition landscape, SWOT analysis and development plans in the near future.
1 Study Coverage
    1.1 Haemophilus Influenzae Type B Vaccine Product Introduction
    1.2 Market by Type
        1.2.1 Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Liquid Monovalent HIB
        1.2.3 Liquid Combination HIB
        1.2.4 Lyophilized Monovalent HIB
        1.2.5 Lyophilized Combination HIB
    1.3 Market by Application
        1.3.1 Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Research Institutions
        1.3.4 Pharmaceutical and Biotechnology Companies
        1.3.5 Academic Institutions
        1.3.6 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Haemophilus Influenzae Type B Vaccine Sales Estimates and Forecasts 2017-2028
    2.2 Global Haemophilus Influenzae Type B Vaccine Revenue Estimates and Forecasts 2017-2028
    2.3 Global Haemophilus Influenzae Type B Vaccine Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Haemophilus Influenzae Type B Vaccine Sales by Region
        2.4.1 Global Haemophilus Influenzae Type B Vaccine Sales by Region (2017-2022)
        2.4.2 Global Sales Haemophilus Influenzae Type B Vaccine by Region (2023-2028)
    2.5 Global Haemophilus Influenzae Type B Vaccine Revenue by Region
        2.5.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2017-2022)
        2.5.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Haemophilus Influenzae Type B Vaccine Sales by Manufacturers
        3.1.1 Global Top Haemophilus Influenzae Type B Vaccine Manufacturers by Sales (2017-2022)
        3.1.2 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Haemophilus Influenzae Type B Vaccine in 2021
    3.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Manufacturers
        3.2.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Manufacturers (2017-2022)
        3.2.2 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Haemophilus Influenzae Type B Vaccine Revenue in 2021
    3.3 Global Haemophilus Influenzae Type B Vaccine Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Haemophilus Influenzae Type B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Haemophilus Influenzae Type B Vaccine Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Haemophilus Influenzae Type B Vaccine Sales by Type
        4.1.1 Global Haemophilus Influenzae Type B Vaccine Historical Sales by Type (2017-2022)
        4.1.2 Global Haemophilus Influenzae Type B Vaccine Forecasted Sales by Type (2023-2028)
        4.1.3 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2017-2028)
    4.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Type
        4.2.1 Global Haemophilus Influenzae Type B Vaccine Historical Revenue by Type (2017-2022)
        4.2.2 Global Haemophilus Influenzae Type B Vaccine Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2017-2028)
    4.3 Global Haemophilus Influenzae Type B Vaccine Price by Type
        4.3.1 Global Haemophilus Influenzae Type B Vaccine Price by Type (2017-2022)
        4.3.2 Global Haemophilus Influenzae Type B Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Haemophilus Influenzae Type B Vaccine Sales by Application
        5.1.1 Global Haemophilus Influenzae Type B Vaccine Historical Sales by Application (2017-2022)
        5.1.2 Global Haemophilus Influenzae Type B Vaccine Forecasted Sales by Application (2023-2028)
        5.1.3 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2017-2028)
    5.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Application
        5.2.1 Global Haemophilus Influenzae Type B Vaccine Historical Revenue by Application (2017-2022)
        5.2.2 Global Haemophilus Influenzae Type B Vaccine Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2017-2028)
    5.3 Global Haemophilus Influenzae Type B Vaccine Price by Application
        5.3.1 Global Haemophilus Influenzae Type B Vaccine Price by Application (2017-2022)
        5.3.2 Global Haemophilus Influenzae Type B Vaccine Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Haemophilus Influenzae Type B Vaccine Market Size by Type
        6.1.1 North America Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2028)
        6.1.2 North America Haemophilus Influenzae Type B Vaccine Revenue by Type (2017-2028)
    6.2 North America Haemophilus Influenzae Type B Vaccine Market Size by Application
        6.2.1 North America Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2028)
        6.2.2 North America Haemophilus Influenzae Type B Vaccine Revenue by Application (2017-2028)
    6.3 North America Haemophilus Influenzae Type B Vaccine Market Size by Country
        6.3.1 North America Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2028)
        6.3.2 North America Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Haemophilus Influenzae Type B Vaccine Market Size by Type
        7.1.1 Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2028)
        7.1.2 Europe Haemophilus Influenzae Type B Vaccine Revenue by Type (2017-2028)
    7.2 Europe Haemophilus Influenzae Type B Vaccine Market Size by Application
        7.2.1 Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2028)
        7.2.2 Europe Haemophilus Influenzae Type B Vaccine Revenue by Application (2017-2028)
    7.3 Europe Haemophilus Influenzae Type B Vaccine Market Size by Country
        7.3.1 Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2028)
        7.3.2 Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Haemophilus Influenzae Type B Vaccine Market Size by Type
        8.1.1 Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2028)
        8.1.2 Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Type (2017-2028)
    8.2 Asia Pacific Haemophilus Influenzae Type B Vaccine Market Size by Application
        8.2.1 Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2028)
        8.2.2 Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Application (2017-2028)
    8.3 Asia Pacific Haemophilus Influenzae Type B Vaccine Market Size by Region
        8.3.1 Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Region (2017-2028)
        8.3.2 Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Haemophilus Influenzae Type B Vaccine Market Size by Type
        9.1.1 Latin America Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2028)
        9.1.2 Latin America Haemophilus Influenzae Type B Vaccine Revenue by Type (2017-2028)
    9.2 Latin America Haemophilus Influenzae Type B Vaccine Market Size by Application
        9.2.1 Latin America Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2028)
        9.2.2 Latin America Haemophilus Influenzae Type B Vaccine Revenue by Application (2017-2028)
    9.3 Latin America Haemophilus Influenzae Type B Vaccine Market Size by Country
        9.3.1 Latin America Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2028)
        9.3.2 Latin America Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Size by Type
        10.1.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Type (2017-2028)
    10.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Size by Application
        10.2.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Application (2017-2028)
    10.3 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Size by Country
        10.3.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Novartis
        11.1.1 Novartis Corporation Information
        11.1.2 Novartis Overview
        11.1.3 Novartis Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Novartis Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Novartis Recent Developments
    11.2 Merck
        11.2.1 Merck Corporation Information
        11.2.2 Merck Overview
        11.2.3 Merck Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Merck Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Merck Recent Developments
    11.3 Sanofi
        11.3.1 Sanofi Corporation Information
        11.3.2 Sanofi Overview
        11.3.3 Sanofi Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Sanofi Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Sanofi Recent Developments
    11.4 GlaxoSmithKline
        11.4.1 GlaxoSmithKline Corporation Information
        11.4.2 GlaxoSmithKline Overview
        11.4.3 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 GlaxoSmithKline Recent Developments
    11.5 Takeda Pharmaceuticals Company
        11.5.1 Takeda Pharmaceuticals Company Corporation Information
        11.5.2 Takeda Pharmaceuticals Company Overview
        11.5.3 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Takeda Pharmaceuticals Company Recent Developments
    11.6 Walvax Biotechnology
        11.6.1 Walvax Biotechnology Corporation Information
        11.6.2 Walvax Biotechnology Overview
        11.6.3 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Walvax Biotechnology Recent Developments
    11.7 Lanzhou Institute of Biologica
        11.7.1 Lanzhou Institute of Biologica Corporation Information
        11.7.2 Lanzhou Institute of Biologica Overview
        11.7.3 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Lanzhou Institute of Biologica Recent Developments
    11.8 Immunize BC
        11.8.1 Immunize BC Corporation Information
        11.8.2 Immunize BC Overview
        11.8.3 Immunize BC Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Immunize BC Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Immunize BC Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Haemophilus Influenzae Type B Vaccine Industry Chain Analysis
    12.2 Haemophilus Influenzae Type B Vaccine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Haemophilus Influenzae Type B Vaccine Production Mode & Process
    12.4 Haemophilus Influenzae Type B Vaccine Sales and Marketing
        12.4.1 Haemophilus Influenzae Type B Vaccine Sales Channels
        12.4.2 Haemophilus Influenzae Type B Vaccine Distributors
    12.5 Haemophilus Influenzae Type B Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Haemophilus Influenzae Type B Vaccine Industry Trends
    13.2 Haemophilus Influenzae Type B Vaccine Market Drivers
    13.3 Haemophilus Influenzae Type B Vaccine Market Challenges
    13.4 Haemophilus Influenzae Type B Vaccine Market Restraints
14 Key Findings in The Global Haemophilus Influenzae Type B Vaccine Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables Table 1. Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Liquid Monovalent HIB Table 3. Major Manufacturers of Liquid Combination HIB Table 4. Major Manufacturers of Lyophilized Monovalent HIB Table 5. Major Manufacturers of Lyophilized Combination HIB Table 6. Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 7. Global Haemophilus Influenzae Type B Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 8. Global Haemophilus Influenzae Type B Vaccine Sales by Region (2017-2022) & (M Doses) Table 9. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2017-2022) Table 10. Global Haemophilus Influenzae Type B Vaccine Sales by Region (2023-2028) & (M Doses) Table 11. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2023-2028) Table 12. Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2017-2022) & (US$ Million) Table 13. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2017-2022) Table 14. Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2023-2028) & (US$ Million) Table 15. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2023-2028) Table 16. Global Haemophilus Influenzae Type B Vaccine Sales by Manufacturers (2017-2022) & (M Doses) Table 17. Global Haemophilus Influenzae Type B Vaccine Sales Share by Manufacturers (2017-2022) Table 18. Global Haemophilus Influenzae Type B Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million) Table 19. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Manufacturers (2017-2022) Table 20. Haemophilus Influenzae Type B Vaccine Price by Manufacturers (2017-2022) &(USD/Dose) Table 21. Global Haemophilus Influenzae Type B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 22. Global Haemophilus Influenzae Type B Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemophilus Influenzae Type B Vaccine as of 2021) Table 23. Haemophilus Influenzae Type B Vaccine Manufacturing Base Distribution and Headquarters Table 24. Manufacturers Haemophilus Influenzae Type B Vaccine Product Offered Table 25. Date of Manufacturers Enter into Haemophilus Influenzae Type B Vaccine Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2022) & (M Doses) Table 28. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2023-2028) & (M Doses) Table 29. Global Haemophilus Influenzae Type B Vaccine Sales Share by Type (2017-2022) Table 30. Global Haemophilus Influenzae Type B Vaccine Sales Share by Type (2023-2028) Table 31. Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2017-2022) & (US$ Million) Table 32. Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2023-2028) & (US$ Million) Table 33. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Type (2017-2022) Table 34. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Type (2023-2028) Table 35. Haemophilus Influenzae Type B Vaccine Price by Type (2017-2022) & (USD/Dose) Table 36. Global Haemophilus Influenzae Type B Vaccine Price Forecast by Type (2023-2028) & (USD/Dose) Table 37. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2022) & (M Doses) Table 38. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2023-2028) & (M Doses) Table 39. Global Haemophilus Influenzae Type B Vaccine Sales Share by Application (2017-2022) Table 40. Global Haemophilus Influenzae Type B Vaccine Sales Share by Application (2023-2028) Table 41. Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2017-2022) & (US$ Million) Table 42. Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2023-2028) & (US$ Million) Table 43. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Application (2017-2022) Table 44. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Application (2023-2028) Table 45. Haemophilus Influenzae Type B Vaccine Price by Application (2017-2022) & (USD/Dose) Table 46. Global Haemophilus Influenzae Type B Vaccine Price Forecast by Application (2023-2028) & (USD/Dose) Table 47. North America Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2022) & (M Doses) Table 48. North America Haemophilus Influenzae Type B Vaccine Sales by Type (2023-2028) & (M Doses) Table 49. North America Haemophilus Influenzae Type B Vaccine Revenue by Type (2017-2022) & (US$ Million) Table 50. North America Haemophilus Influenzae Type B Vaccine Revenue by Type (2023-2028) & (US$ Million) Table 51. North America Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2022) & (M Doses) Table 52. North America Haemophilus Influenzae Type B Vaccine Sales by Application (2023-2028) & (M Doses) Table 53. North America Haemophilus Influenzae Type B Vaccine Revenue by Application (2017-2022) & (US$ Million) Table 54. North America Haemophilus Influenzae Type B Vaccine Revenue by Application (2023-2028) & (US$ Million) Table 55. North America Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2022) & (M Doses) Table 56. North America Haemophilus Influenzae Type B Vaccine Sales by Country (2023-2028) & (M Doses) Table 57. North America Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2022) & (US$ Million) Table 58. North America Haemophilus Influenzae Type B Vaccine Revenue by Country (2023-2028) & (US$ Million) Table 59. Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2022) & (M Doses) Table 60. Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2023-2028) & (M Doses) Table 61. Europe Haemophilus Influenzae Type B Vaccine Revenue by Type (2017-2022) & (US$ Million) Table 62. Europe Haemophilus Influenzae Type B Vaccine Revenue by Type (2023-2028) & (US$ Million) Table 63. Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2022) & (M Doses) Table 64. Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2023-2028) & (M Doses) Table 65. Europe Haemophilus Influenzae Type B Vaccine Revenue by Application (2017-2022) & (US$ Million) Table 66. Europe Haemophilus Influenzae Type B Vaccine Revenue by Application (2023-2028) & (US$ Million) Table 67. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2022) & (M Doses) Table 68. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2023-2028) & (M Doses) Table 69. Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2022) & (US$ Million) Table 70. Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2023-2028) & (US$ Million) Table 71. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2022) & (M Doses) Table 72. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Type (2023-2028) & (M Doses) Table 73. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Type (2017-2022) & (US$ Million) Table 74. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Type (2023-2028) & (US$ Million) Table 75. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2022) & (M Doses) Table 76. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Application (2023-2028) & (M Doses) Table 77. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Application (2017-2022) & (US$ Million) Table 78. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Application (2023-2028) & (US$ Million) Table 79. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Region (2017-2022) & (M Doses) Table 80. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Region (2023-2028) & (M Doses) Table 81. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Region (2017-2022) & (US$ Million) Table 82. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Region (2023-2028) & (US$ Million) Table 83. Latin America Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2022) & (M Doses) Table 84. Latin America Haemophilus Influenzae Type B Vaccine Sales by Type (2023-2028) & (M Doses) Table 85. Latin America Haemophilus Influenzae Type B Vaccine Revenue by Type (2017-2022) & (US$ Million) Table 86. Latin America Haemophilus Influenzae Type B Vaccine Revenue by Type (2023-2028) & (US$ Million) Table 87. Latin America Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2022) & (M Doses) Table 88. Latin America Haemophilus Influenzae Type B Vaccine Sales by Application (2023-2028) & (M Doses) Table 89. Latin America Haemophilus Influenzae Type B Vaccine Revenue by Application (2017-2022) & (US$ Million) Table 90. Latin America Haemophilus Influenzae Type B Vaccine Revenue by Application (2023-2028) & (US$ Million) Table 91. Latin America Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2022) & (M Doses) Table 92. Latin America Haemophilus Influenzae Type B Vaccine Sales by Country (2023-2028) & (M Doses) Table 93. Latin America Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2022) & (US$ Million) Table 94. Latin America Haemophilus Influenzae Type B Vaccine Revenue by Country (2023-2028) & (US$ Million) Table 95. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2022) & (M Doses) Table 96. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Type (2023-2028) & (M Doses) Table 97. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Type (2017-2022) & (US$ Million) Table 98. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Type (2023-2028) & (US$ Million) Table 99. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2022) & (M Doses) Table 100. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Application (2023-2028) & (M Doses) Table 101. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Application (2017-2022) & (US$ Million) Table 102. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Application (2023-2028) & (US$ Million) Table 103. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2022) & (M Doses) Table 104. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2023-2028) & (M Doses) Table 105. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2022) & (US$ Million) Table 106. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Country (2023-2028) & (US$ Million) Table 107. Novartis Corporation Information Table 108. Novartis Description and Major Businesses Table 109. Novartis Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 110. Novartis Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 111. Novartis Recent Developments Table 112. Merck Corporation Information Table 113. Merck Description and Major Businesses Table 114. Merck Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 115. Merck Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 116. Merck Recent Developments Table 117. Sanofi Corporation Information Table 118. Sanofi Description and Major Businesses Table 119. Sanofi Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 120. Sanofi Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 121. Sanofi Recent Developments Table 122. GlaxoSmithKline Corporation Information Table 123. GlaxoSmithKline Description and Major Businesses Table 124. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 125. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 126. GlaxoSmithKline Recent Developments Table 127. Takeda Pharmaceuticals Company Corporation Information Table 128. Takeda Pharmaceuticals Company Description and Major Businesses Table 129. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 130. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 131. Takeda Pharmaceuticals Company Recent Developments Table 132. Walvax Biotechnology Corporation Information Table 133. Walvax Biotechnology Description and Major Businesses Table 134. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 135. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 136. Walvax Biotechnology Recent Developments Table 137. Lanzhou Institute of Biologica Corporation Information Table 138. Lanzhou Institute of Biologica Description and Major Businesses Table 139. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 140. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 141. Lanzhou Institute of Biologica Recent Developments Table 142. Immunize BC Corporation Information Table 143. Immunize BC Description and Major Businesses Table 144. Immunize BC Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 145. Immunize BC Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 146. Immunize BC Recent Developments Table 147. Key Raw Materials Lists Table 148. Raw Materials Key Suppliers Lists Table 149. Haemophilus Influenzae Type B Vaccine Distributors List Table 150. Haemophilus Influenzae Type B Vaccine Customers List Table 151. Haemophilus Influenzae Type B Vaccine Market Trends Table 152. Haemophilus Influenzae Type B Vaccine Market Drivers Table 153. Haemophilus Influenzae Type B Vaccine Market Challenges Table 154. Haemophilus Influenzae Type B Vaccine Market Restraints Table 155. Research Programs/Design for This Report Table 156. Key Data Information from Secondary Sources Table 157. Key Data Information from Primary Sources List of Figures Figure 1. Haemophilus Influenzae Type B Vaccine Product Picture Figure 3. Global Haemophilus Influenzae Type B Vaccine Market Share by Type in 2021 & 2028 Figure 3. Liquid Monovalent HIB Product Picture Figure 4. Liquid Combination HIB Product Picture Figure 5. Lyophilized Monovalent HIB Product Picture Figure 6. Lyophilized Combination HIB Product Picture Figure 7. Global Haemophilus Influenzae Type B Vaccine Market Share by Application in 2021 & 2028 Figure 8. Hospital Figure 9. Research Institutions Figure 10. Pharmaceutical and Biotechnology Companies Figure 11. Academic Institutions Figure 12. Other Figure 13. Haemophilus Influenzae Type B Vaccine Report Years Considered Figure 14. Global Haemophilus Influenzae Type B Vaccine Sales 2017-2028 (M Doses) Figure 15. Global Haemophilus Influenzae Type B Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 16. Global Haemophilus Influenzae Type B Vaccine Revenue 2017-2028 (US$ Million) Figure 17. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 18. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2017-2022) Figure 19. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2023-2028) Figure 20. North America Haemophilus Influenzae Type B Vaccine Sales YoY (2017-2028) & (M Doses) Figure 21. North America Haemophilus Influenzae Type B Vaccine Revenue YoY (2017-2028) & (US$ Million) Figure 22. Europe Haemophilus Influenzae Type B Vaccine Sales YoY (2017-2028) & (M Doses) Figure 23. Europe Haemophilus Influenzae Type B Vaccine Revenue YoY (2017-2028) & (US$ Million) Figure 24. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales YoY (2017-2028) & (M Doses) Figure 25. Asia-Pacific Haemophilus Influenzae Type B Vaccine Revenue YoY (2017-2028) & (US$ Million) Figure 26. Latin America Haemophilus Influenzae Type B Vaccine Sales YoY (2017-2028) & (M Doses) Figure 27. Latin America Haemophilus Influenzae Type B Vaccine Revenue YoY (2017-2028) & (US$ Million) Figure 28. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales YoY (2017-2028) & (M Doses) Figure 29. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue YoY (2017-2028) & (US$ Million) Figure 30. The Haemophilus Influenzae Type B Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 31. The Top 5 and 10 Largest Manufacturers of Haemophilus Influenzae Type B Vaccine in the World: Market Share by Haemophilus Influenzae Type B Vaccine Revenue in 2021 Figure 32. Global Haemophilus Influenzae Type B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 33. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2017-2028) Figure 34. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2017-2028) Figure 35. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2017-2028) Figure 36. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2017-2028) Figure 37. North America Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2017-2028) Figure 38. North America Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2017-2028) Figure 39. North America Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2017-2028) Figure 40. North America Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2017-2028) Figure 41. North America Haemophilus Influenzae Type B Vaccine Sales Share by Country (2017-2028) Figure 42. North America Haemophilus Influenzae Type B Vaccine Revenue Share by Country (2017-2028) Figure 43. U.S. Haemophilus Influenzae Type B Vaccine Revenue (2017-2028) & (US$ Million) Figure 44. Canada Haemophilus Influenzae Type B Vaccine Revenue (2017-2028) & (US$ Million) Figure 45. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2017-2028) Figure 46. Europe Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2017-2028) Figure 47. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2017-2028) Figure 48. Europe Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2017-2028) Figure 49. Europe Haemophilus Influenzae Type B Vaccine Sales Share by Country (2017-2028) Figure 50. Europe Haemophilus Influenzae Type B Vaccine Revenue Share by Country (2017-2028) Figure 51. Germany Haemophilus Influenzae Type B Vaccine Revenue (2017-2028) & (US$ Million) Figure 52. France Haemophilus Influenzae Type B Vaccine Revenue (2017-2028) & (US$ Million) Figure 53. U.K. Haemophilus Influenzae Type B Vaccine Revenue (2017-2028) & (US$ Million) Figure 54. Italy Haemophilus Influenzae Type B Vaccine Revenue (2017-2028) & (US$ Million) Figure 55. Russia Haemophilus Influenzae Type B Vaccine Revenue (2017-2028) & (US$ Million) Figure 56. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2017-2028) Figure 57. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2017-2028) Figure 58. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2017-2028) Figure 59. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2017-2028) Figure 60. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales Share by Region (2017-2028) Figure 61. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue Share by Region (2017-2028) Figure 62. China Haemophilus Influenzae Type B Vaccine Revenue (2017-2028) & (US$ Million) Figure 63. Japan Haemophilus Influenzae Type B Vaccine Revenue (2017-2028) & (US$ Million) Figure 64. South Korea Haemophilus Influenzae Type B Vaccine Revenue (2017-2028) & (US$ Million) Figure 65. India Haemophilus Influenzae Type B Vaccine Revenue (2017-2028) & (US$ Million) Figure 66. Australia Haemophilus Influenzae Type B Vaccine Revenue (2017-2028) & (US$ Million) Figure 67. Taiwan Haemophilus Influenzae Type B Vaccine Revenue (2017-2028) & (US$ Million) Figure 68. Indonesia Haemophilus Influenzae Type B Vaccine Revenue (2017-2028) & (US$ Million) Figure 69. Thailand Haemophilus Influenzae Type B Vaccine Revenue (2017-2028) & (US$ Million) Figure 70. Malaysia Haemophilus Influenzae Type B Vaccine Revenue (2017-2028) & (US$ Million) Figure 71. Philippines Haemophilus Influenzae Type B Vaccine Revenue (2017-2028) & (US$ Million) Figure 72. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2017-2028) Figure 73. Latin America Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2017-2028) Figure 74. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2017-2028) Figure 75. Latin America Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2017-2028) Figure 76. Latin America Haemophilus Influenzae Type B Vaccine Sales Share by Country (2017-2028) Figure 77. Latin America Haemophilus Influenzae Type B Vaccine Revenue Share by Country (2017-2028) Figure 78. Mexico Haemophilus Influenzae Type B Vaccine Revenue (2017-2028) & (US$ Million) Figure 79. Brazil Haemophilus Influenzae Type B Vaccine Revenue (2017-2028) & (US$ Million) Figure 80. Argentina Haemophilus Influenzae Type B Vaccine Revenue (2017-2028) & (US$ Million) Figure 81. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2017-2028) Figure 82. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2017-2028) Figure 83. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2017-2028) Figure 84. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2017-2028) Figure 85. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Share by Country (2017-2028) Figure 86. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue Share by Country (2017-2028) Figure 87. Turkey Haemophilus Influenzae Type B Vaccine Revenue (2017-2028) & (US$ Million) Figure 88. Saudi Arabia Haemophilus Influenzae Type B Vaccine Revenue (2017-2028) & (US$ Million) Figure 89. U.A.E Haemophilus Influenzae Type B Vaccine Revenue (2017-2028) & (US$ Million) Figure 90. Haemophilus Influenzae Type B Vaccine Value Chain Figure 91. Haemophilus Influenzae Type B Vaccine Production Process Figure 92. Channels of Distribution Figure 93. Distributors Profiles Figure 94. Bottom-up and Top-down Approaches for This Report Figure 95. Data Triangulation Figure 96. Key Executives Interviewed



Inquiry before buying

Request Sample

Request for Discount

Latest News

Global Cancer Immunotherapy Market to Grow at a (CAGR) of 13.9% during the Forecast Period 2022-2030

18-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the global  Cancer Immunotherapy Market is projected to reach USD 275.5 billion by 2030. Moreover, increasing day-by-day incidence of cancer, increasing awareness about early diagnosis, the effectiveness of thera ...

Global In-Vehicle Infotainment Market to Grow at a (CAGR) of 9.8% during the Forecast Period 2022-2030

17-Nov-2022 | Automobile

As specified in our exclusive report, the global  In-Vehicle Infotainment Market is projected to reach USD 42.25 billion by 2030. In-vehicle infotainment systems provide entertainment and information services to the driver and passengers throughou ...

Global Blockchain in Healthcare Market to Grow at a (CAGR) of 59% during the Forecast Period 2022-2030

16-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the global Blockchain in Healthcare Market is projected to reach USD 119 billion by 2030. The growing need for curbing these issues along with the increasing incidence of information leaks and data breaches has be ...

Global In Vitro Fertilization Market to Grow at a (CAGR) of 5.7% during the Forecast Period 2022-2030

14-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the Global In-Vitro Fertilization Market is projected to reach USD 32 billion by 2030. In-vitro fertilization involves some risks such as genetic disease transfer during the pr ...

Global Microfluidics Market to Grow at a (CAGR) of 15.8% during the Forecast Period 2022-2030

11-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the global  Microfluidics Market is projected to reach USD 61 billion by 2030. The growth in demand for point-of-care (POC) devices is expected to majorly drive the market size in the coming years. Simultaneously demand ...

More News...